Important Safety Information
Full Prescribing Information
Visit Peer2Peer Clinical Education
About
OMIDRIA
This page is intended for educational purposes, using scientific exchange around the OMIDRIA experience.
Surgical Cases
Preoperative Poor Dilation
Stability of pupil size throughout the entire case
IFIS-Risk Patient
Patient currently using an ɑ-blocker
Hyperopia + Tamsulosin
Patient with +2D hyperopia and tamsulosin history
Patients At-Risk for IFIS
ɑ-blocker history: a side by side OMIDRIA/No OMIDRIA
Intraoperative Miosis
Intraoperative miosis without ɑ-blocker history
Peer2Peer Perspectives
Witness Dramatic Change
See why Drs. Wiley and Hura started using OMIDRIA
One Vial, Lasting Effects
OMIDRIA’s intra- and postoperative experience
The Proof Is in the Post-Op
Learn why Drs. Wiley and Hura recommend OMIDRIA
The Ketorolac Effect
Learn how OMIDRIA suppresses COX-1 and COX-2
Proven to Maintain Dilation
Hear Dr. Walter describe OMIDRIA’s effect on miosis
A Case of Premium Outcomes
See how OMIDRIA supports patients’ desired outcomes
I Wasn’t an Early Adopter
Hear about Dr. Walter’s journey to using OMIDRIA
A Prospective Study
Hear Dr. Silverstein share OMIDRIA Study Results
Why I Choose OMIDRIA
See why Dr. Walter recommends OMIDRIA
OMIDRIA Study Results
Drs. Visco and Walter discuss OMIDRIA study and results
The Challenges of Miosis
Dr. Silverstein on the impact of pupillary miosis
Walter: OMIDRIA Benefits
Hear how OMIDRIA can benefit you and your patients
Visco: OMIDRIA Benefits
Hear how OMIDRIA can benefit your practice
EXPLORE SURGEON PERSPECTIVES
Indications and Usage
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
Important Safety Information
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Indications and Usage
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
Important Safety Information
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.